cardiac events
Bisoprolol reduced the incidence of nonlethal       cardiac events in patients in whom heart failure was present for at least 4 years       (RR 0.44; 95% CI 0.27 to 0.71; P <.01).
Bisoprolol reduced the incidence of nonlethal        @SUBJECT$   @PREDICAT$   @OBJECT$  in whom heart failure was present for at least 4 years       (RR 0.44; 95% CI 0.27 to 0.71; P <.01).